U.S. Food and Drug Administration Approves Longeveron’s Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to U.S. Food and Drug Administration Approves Longeveron’s Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition
LOGICVISION (NASDAQ: LGVN) Delayed: 0.80 -0.02 (2.44%)
Previous Close $0.82    52 Week High $1.62 
Open $0.84    52 Week Low $0.35 
Day High $0.85    P/E N/A 
Day Low $0.80    EPS $-0.17 
Volume 394,032